Skip to main content

Oxyfrin Side Effects

Generic name: oxymetazoline nasal

Medically reviewed by Drugs.com. Last updated on Mar 18, 2024.

Note: This document provides detailed information about Oxyfrin Side Effects associated with oxymetazoline nasal. Some dosage forms listed on this page may not apply specifically to the brand name Oxyfrin.

Applies to oxymetazoline nasal: nasal spray.

Serious side effects of Oxyfrin

Along with its needed effects, oxymetazoline nasal (the active ingredient contained in Oxyfrin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking oxymetazoline nasal:

Other side effects of Oxyfrin

Some side effects of oxymetazoline nasal may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to oxymetazoline nasal: nasal solution, nasal spray.

General

The most commonly reported side effects were discomfort or irritation in the nose, mouth or throat, and sneezing.[Ref]

Gastrointestinal

Cardiovascular

Nervous system

Ocular

Respiratory

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics."

2. Cerner Multum, Inc. "Australian Product Information."

3. (2001) "Product Information. Afrin (oxymetazoline nasal)." Schering-Plough

Frequently asked questions

Further information

Oxyfrin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.